This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

BioScrip Inc (BIOS)

NASDAQ: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) -69.65M 64.71M 0.00 -69.14M
Operating Gains/Losses 16.57M 156.00K 404.00K 9.91M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -31.86M 101.23M -31.69M -4.32M
(Increase) Decrease in Inventories 4.94M -15.25M 9.78M -11.02M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 22.14M -48.20M -1.66M 2.94M
(Decrease) Increase In Other Current Liabilities -9.28M 8.09M 2.55M -3.65M
(Increase) Decrease In Other Working Capital -17.95M -11.40M 8.73M -1.03M
Other Non-Cash Items 19.71M -66.92M 12.34M 3.32M
Net Cash From Continuing Operations -38.50M 49.86M 26.97M -21.42M
Net Cash From Discontinued Operations -16.05M -22.98M 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -54.55M 26.88M 26.97M -21.42M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment 0.00 -10.99M -9.44M -11.11M
Acquisitions -285.36M -13.59M 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities -17.01M -43.05M -463.00K -97.43M
Cash Provided by Financing Activities
Net Cash From Investing Activities -302.37M 93.88M -9.91M -108.55M
Issuance of Debt 827.65M 1.24B 1.77B 319.00M
Cash Used for Financing Activities
Issuance of Capital Stock 120.93M 8.61M 3.20M 4.12M
Repayment of Long-Term Debt -652.76M -1.31B -1.79B -180.44M
Repurchase of Capital Stock 0.00 0.00 0.00 -128.00K
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net 0.00 -174.00K -211.00K -12.58M
Net Cash From Financing Activities 295.82M -58.66M -17.06M 129.97M
Effect of Exchange Rate Changes 0.00 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -61.10M 62.10M 0.00 0.00

Analysts Ratings for BIOS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 3
Moderate Buy 2 2 2 2
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

BIOS Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs